Table 1.
Drug | Concentration (μM) | Vehicle | Cell lines | Time of exposure (h) |
---|---|---|---|---|
Cocaine | 10 | Water | SH-SY5Y/BE(2)-M17 | 24* |
Desipramine | 10 | Methanol | SH-SY5Y/BE(2)-M17 | 24 |
DMT | 100 | Water | SH-SY5Y/BE(2)-M17 | 24* |
5-MeO-DMT | 10 | Water | SH-SY5Y/BE(2)-M17 | 24* |
Harmaline | 10 | Water | SH-SY5Y/BE(2)-M17 | 24* |
Disulfiram | 1 | DMSO | SH-SY5Y/BE(2)-M17 | 24 |
Fluoxetine | 10 | Water | SH-SY5Y/BE(2)-M17 | 24 |
Methadone | 10 | Water | SH-SY5Y/BE(2)-M17 | 24 |
Methylphenidate | 10 | Water | SH-SY5Y/BE(2)-M17 | 24* |
Bilobalide | 100 | DMSO | MCF-7/ Caco-2 | 48 |
Daidzein | 30 | DMSO | MCF-7/ Caco-2 | 48 |
Dexamethasone | 5 | DMSO | MCF-7/ Caco-2 | 48 |
Doxorubicin | 10 | Water | MCF-7/ Caco-2 | 48 |
Gemcitabine | 10 | Water | MCF-7/ Caco-2 | 48 |
Imatinib | 10 | Water | MCF-7/ Caco-2 | 48 |
Mitoxantrone | 5 | Water | MCF-7/ Caco-2 | 48 |
Tanshinone IIA | 1 | DMSO | MCF-7/ Caco-2 | 48 |
Taxol | 5 | DMSO | MCF-7/ Caco-2 | 48 |
Vinblastine | 1 | Water | MCF-7/ Caco-2 | 48 |
Multiple doses; cells treated every 8 h during a 24-h period.